Treatment of Acute Non-Lymphocytic Leukemia with Conventional Induction, Consolidation Chemotherapy: Maintenance with Chemotherapy Versus Bone Marrow Transplantation Following Total Body Irradiation
Publication Information Expand/Collapse
Racial disparities in survival of patients with sex-specific cancers treated on Southwest Oncology Group clinical trials. PMC2724852; PMID: 19584328
Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systemic review and meta-analysis of prospective clinical trials [PMID9509382;PMC3163846]
Minority report: how best to analyze clinical trial data to address disparities
Long-term survival after chemotherapy for acute myeloid leukemia: The experience of the Southwest Oncology Group.
Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia.
A prospective evaluation of the roles of allogeneic marrow transplantation and low-dose monthly maintenance chemotherapy in the treatment of adult acute myelogenous leukemia (AML): A Southwest Oncology Group study
Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience.
Reply to comments by Fenaux and Warrell.
Background dysplasia in acute myeloblastic leukemia (AML).
Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages.
Survival with cytotoxic therapy in acute promyelocytic leukemia. A Southwest Oncology Group report.
Significance of HLA-DR and FC receptor expression in acute non-lymphoblastic leukemia (ANLL).
Prognostic factor analysis of the outcome of marrowtransplantation or further chemotherapy for acute nonlymphocyticleukemia.
Prospective comparative study of bone marrow transplantation (BMT)versus continued chemotherapy for adult acute nonlymphocytic leukemia(ANL): A Southwest Oncology Group study.